Winslow Evans & Crocker Inc. Acquires 5,772 Shares of Qiagen N.V. (QGEN)

Winslow Evans & Crocker Inc. raised its position in Qiagen N.V. (NASDAQ:QGEN) by 419.5% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 7,148 shares of the company’s stock after buying an additional 5,772 shares during the period. Winslow Evans & Crocker Inc.’s holdings in Qiagen N.V. were worth $226,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in QGEN. Wetherby Asset Management Inc. boosted its position in Qiagen N.V. by 1.8% in the first quarter. Wetherby Asset Management Inc. now owns 9,273 shares of the company’s stock worth $269,000 after buying an additional 163 shares in the last quarter. Dimensional Fund Advisors LP boosted its position in Qiagen N.V. by 0.4% in the first quarter. Dimensional Fund Advisors LP now owns 73,215 shares of the company’s stock worth $2,121,000 after buying an additional 306 shares in the last quarter. Capstone Asset Management Co. boosted its position in Qiagen N.V. by 1.2% in the second quarter. Capstone Asset Management Co. now owns 75,003 shares of the company’s stock worth $2,515,000 after buying an additional 873 shares in the last quarter. Opus Point Partners Management LLC boosted its position in Qiagen N.V. by 1.0% in the fourth quarter. Opus Point Partners Management LLC now owns 111,683 shares of the company’s stock worth $3,129,000 after buying an additional 1,118 shares in the last quarter. Finally, Parametrica Management Ltd boosted its position in Qiagen N.V. by 38.7% in the first quarter. Parametrica Management Ltd now owns 10,107 shares of the company’s stock worth $293,000 after buying an additional 2,818 shares in the last quarter. Institutional investors and hedge funds own 61.03% of the company’s stock.

Qiagen N.V. (NASDAQ QGEN) opened at 34.07 on Monday. Qiagen N.V. has a one year low of $22.80 and a one year high of $35.26. The stock has a market capitalization of $7.76 billion, a PE ratio of 94.64 and a beta of 1.15. The company’s 50-day moving average price is $33.63 and its 200-day moving average price is $30.30.

COPYRIGHT VIOLATION NOTICE: “Winslow Evans & Crocker Inc. Acquires 5,772 Shares of Qiagen N.V. (QGEN)” was posted by Ticker Report and is the property of of Ticker Report. If you are viewing this news story on another publication, it was copied illegally and reposted in violation of US & international copyright & trademark legislation. The original version of this news story can be accessed at https://www.tickerreport.com/banking-finance/2722295/winslow-evans-crocker-inc-acquires-5772-shares-of-qiagen-n-v-qgen.html.

A number of research firms have recently weighed in on QGEN. Evercore ISI increased their price target on Qiagen N.V. from $30.00 to $31.50 and gave the stock an “outperform” rating in a report on Thursday, May 4th. TheStreet upgraded Qiagen N.V. from a “c” rating to a “b” rating in a report on Monday, June 5th. BidaskClub cut Qiagen N.V. from a “strong-buy” rating to a “buy” rating in a report on Saturday, June 10th. Commerzbank Ag reiterated a “buy” rating on shares of Qiagen N.V. in a report on Monday, May 15th. Finally, DZ Bank AG reiterated a “neutral” rating on shares of Qiagen N.V. in a report on Monday, May 29th. Nine analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average target price of $29.56.

Qiagen N.V. Company Profile

QIAGEN N.V. (QIAGEN) is a holding company. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials.

Want to see what other hedge funds are holding QGEN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Qiagen N.V. (NASDAQ:QGEN).

Institutional Ownership by Quarter for Qiagen N.V. (NASDAQ:QGEN)

Receive News & Ratings for Qiagen N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Qiagen N.V. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


Leave a Reply

© 2006-2017 Ticker Report. Google+.